Johnson & Johnson appoints Michaela Hagenhofer as Irish GM [Video]

Johnson & Johnson Innovative Medicine has appointed Michaela Hagenhofer as general manager of its commercial operations for Ireland.

Hagenhofer will be responsible for leading all aspects of the company’s commercial business in Ireland, and will focus on sustainable business growth through enhanced access to innovative therapies.

She previously served as commercial director for speciality care at J&J Innovative Medicine in Austria, achieving consistent growth across immunology, central nervous system, and cardiopulmonary therapies.

Hagenhofer previously worked for Takeda, AbbVie and Merck in roles spanning haematology, oncology and gastroenterology.

J&J Innovative Medicine’s R&D is currently focused on oncology, immunology, neuroscience, cardiopulmonary and speciality ophthalmology.

Commenting on her appointment, Hagenhofer said: “Taking on the role of general manager for Johnson & Johnson Innovative Medicine commercial operations Ireland is an exciting next chapter in my career. 

“As a business, we are committed to leading where medicine is going, identifying the patients with the highest unmet need and developing increasingly personalised care for specific …